Tezted Ltd is innovating the way infectious diseases are diagnosed with a focus on tick-borne diseases and Covid-19.
08/03/2026
🌍✨ Happy International Women's Day 2025! ✨🌍
Today, we celebrate the extraordinary achievements and relentless spirit of women around the globe. From scientists breaking new ground, educators shaping the future, athletes defying limits, artists creating beauty and business leaders driving change - women are at the forefront of progress in every field.
This day is a tribute to the diverse and powerful voices of women - Caucasian, Hispanic, Black, Middle-Eastern, South Asian, East Asian, and more. Each one is an essential thread in the rich tapestry of our global community.
Let's honour the courage, creativity, and resilience of women everywhere. Their dreams, struggles, and triumphs inspire us all. As we look at our world, let's commit to fostering an environment where every woman and girl can realize her full potential.
Here's to equality, respect, and empowerment. Today and every day, let's uplift and support each other, building a brighter, more inclusive future for all.
04/03/2026
From the 1st Annual Conference on Chronic Infection Pathologies: Dr. Stanley Naides – Pathogen Induction of Autoimmunity: Can a Virus Modify Self Antigens?
The immune system is designed to ignore our own DNA.
But under certain conditions, that tolerance can break.
1st Annual Conference on Chronic Infection Pathologies – SHOW ME THE DATA! Took place on 5-7 September, 2025, in Jyväskylä Finland.
At the event, 150 participants, both online and onsite, from 16 different countries gathered to explore the current landscape of treatment and research related to chronic illnesses.
Follow us, as in the following weeks we’ll be sharing highlights and full recordings of the insightful presentations shown during the event.
03/03/2026
On 5-7 September, 2025, we hosted the 1st Annual Conference on Chronic Infection Pathologies, which included a myriad of insightful presentations on the topic of tick-borne and chronic illnesses.
Stanley Naides presented us with: Pathogen Induction of Autoimmunity: Can a Virus Modify Self Antigens?
SAVE THE DATE | Istanbul, Turkey | September 2026 ABSTRACTS SUBMISSIONS ARE OPEN
Join us for the 2nd Annual Conference on Chronic Infection Pathologies (CIP) — From Data to Diagnosis — bringing together clinicians, laboratory scientists, researchers, and patients to advance how we evaluate and manage complex chronic infection and post-infectious conditions.
Conference dates under consideration: Sept 3–6, 2026 (alternate dates: Sept 17–20, 2026)
Pre-conference workshop: Thursday afternoon (½ day) — a hands-on, clinician + lab scientist–led session on diagnostic tools and result interpretation: pros/cons, limitations, “good/bad/ugly,” and best-practice approaches.
Key topics include: Lyme disease, Long COVID, and infectious disease challenges of the 21st century.
Interested in attending, presenting, or sponsoring? Email: info@chronicinfectionpathologies.com
20/02/2026
SAVE THE DATE | Istanbul, Turkey | September 2026
Join us for the 2nd Annual Conference on Chronic Infection Pathologies (CIP) — From Data to Diagnosis — bringing together clinicians, laboratory scientists, researchers, and patients to advance how we evaluate and manage complex chronic infection and post-infectious conditions.
Conference dates under consideration: Sept 3–6, 2026 (alternate dates: Sept 17–20, 2026)
Pre-conference workshop: Thursday afternoon (½ day) — a hands-on, clinician + lab scientist–led session on diagnostic tools and result interpretation: pros/cons, limitations, “good/bad/ugly,” and best-practice approaches.
Key topics include: Lyme disease, Long COVID, and infectious disease challenges of the 21st century.
Interested in attending, presenting, or sponsoring? Email: info@chronicinfectionpathologies.com
19/02/2026
If you see patients where Lyme disease (and possible co-infections) is on the differential, you might find this webinar useful.
Modernizing the Two-Tier Diagnostic Framework: Improving Accuracy in Lyme and Co-Infection Testing
We’ll talk through where the traditional two-tier approach can fall short in real-world practice—and what a more modern testing strategy can look like when cases are complex, persistent, or don’t fit the textbook.
📅 Monday, February 23
🕘 9 AM Pacific | 10 AM Mountain | 11 AM Central | 12 PM Eastern
From the 1st Annual Conference on Chronic Infection Pathologies:
Dr. Aylin Ozdemir – Understanding Neuropsychiatric and Neurological Complexities in Lyme Disease and Co-Infections
Complex diseases often arise from intricate causes, and their treatment should align accordingly.
In Ozdemir’s cases, all patients exhibited multiple overlapping infections, which were only identified through specialized testing.
1st Annual Conference on Chronic Infection Pathologies – SHOW ME THE DATA! Took place on 5-7 September, 2025, in Jyväskylä Finland.
At the event, 150 participants, both online and onsite, from 16 different countries gathered to explore the current landscape of treatment and research related to chronic illnesses.
Follow us, as in the following weeks we’ll be sharing highlights and full recordings of the insightful presentations shown during the event.
17/02/2026
On 5-7 September, 2025, we hosted the 1st Annual Conference on Chronic Infection Pathologies, which included a myriad of insightful presentations on the topic of tick-borne and chronic illnesses.
Dr. Aylin Ozdemir presented us with: Understanding Neuropsychiatric and Neurological Complexities in Lyme Disease and Co-Infections
1st Annual Conference on Chronic Infection Pathologies – SHOW ME THE DATA! Took place on 5-7 September, 2025, in Jyväskylä Finland.
At the event, 150 participants, both online and onsite, from 16 different countries gathered to explore the current landscape of treatment and research related to chronic illnesses.
Follow us, as in the following weeks we’ll be sharing highlights and full recordings of the insightful presentations shown during the event.
Tiedä ensimmäisenä ja anna meille oikeus lähettää sinulle sähköpostitse uutisia ja promootioita Te?ted Oy - Tezted :ltä. Sähköpostiosoitettasi ei käytetä muihin tarkoituksiin, ja voit perua milloin tahansa.
Lets get the patient tested so they can be treated and recover quicker
Tickplex Validation Process
Te?ted Oy is a university spin off company from research work conducted under Dr. Leona Gilbert, and Te?ted Oy is now manufacturing and selling to clinical laboratories TICKPLEX Products. TICKPLEX in itself was a research project at under Dr. Leona Gilbert’s research team from July 2015 to Sept 2016 funded by the Finnish Funding Agency for Innovation, (Finnish Government) now called Business Finland. Within this project we have scientifically validated the test kit as reported in the “Validation Paper” and also peer reviewed in the Nature's Scientific Reports paper found at this site https://www.nature.com/articles/s41598-018-34393-9
As soon as Te?ted Oy was established, TICKPLEX Products, (Basic and Plus test kits) underwent an additional scientific and clinical validation according to all appropriate laws; EU IVD Directive (In vitro diagnostic medical devices directive) 98/79/EC and the Finnish Medical Device Law Regarding Healthcare, Devices and Supplies 2010/629 that lead to its IVD CE conformity declaration. Our test kits also conformed as declared to the following relevant harmonized standards used of references to the other technical specifications in relation to which conformity is declared:
- SFS-EN ISO 14971 Medical devices. Application of risk management to medical devices.
- SFS-EN 13612n + AC Performance evaluation of in vitro diagnostic medical devices.
- SFS-EN ISO 23640 In vitro diagnostic medical devices. Evaluation of stability of in vitro medical
reagents.
- SFS-EN ISO 18113-1 In vitro diagnostic medical devices. Information supplied by the
manufacturer (labelling). Part 1: terms, definitions and general requirements.
- SFS-EN-ISO 18113-2. Part 1: terms, definitions and general requirements.
- SFS-EN 15223-1:2016 Medical devices. Symbols to be used with medical device label, labelling and information supplied. Part 1: General requirements.
These products are registered with the national regulatory authorities here in Finland as ascribed by the law. In addition, the national regulatory authority conducted a routine inspection and found that we are conducting business and manufacturing according to the laws. Te?ted Oy company even went further to provide credibility with its processes and manufacturing and was accredited ISO 13485:2016 qualification through an external auditor, Lloyd’s Register LRQA. In order for any clinical lab to start selling our test kits, they have to independently validate the test kit as directed by the law, EU IVD Directive 98/79/EC. It is the law which means that this test kit has been independently validated. At the moment TICKPLEX Products have been validated independently in clinical laboratories that have expertise in diagnosing tick-borne diseases, in Germany, Poland, Netherlands, USA and Finland. All the best Te?ted Oy Team
